193 related articles for article (PubMed ID: 34844023)
21. A new type of acquired C1 inhibitor deficiency associated with systemic lupus erythematosus.
Cacoub P; Frémeaux-Bacchi V; De Lacroix I; Guillien F; Kahn MF; Kazatchkine MD; Godeau P; Piette JC
Arthritis Rheum; 2001 Aug; 44(8):1836-40. PubMed ID: 11508436
[TBL] [Abstract][Full Text] [Related]
22. Recurrent Angioedema: Occurrence, Features, and Concomitant Diseases in an Italian Single-Center Study.
Triggianese P; Guarino MD; Pellicano C; Borzi M; Greco E; Modica S; De Carolis C; Perricone R
Int Arch Allergy Immunol; 2017; 172(1):55-63. PubMed ID: 28222436
[TBL] [Abstract][Full Text] [Related]
23. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.
Zeerleder S; Levi M
Ann Med; 2016; 48(4):256-67. PubMed ID: 27018196
[TBL] [Abstract][Full Text] [Related]
24. C1-inhibitor/C1-inhibitor antibody complexes in acquired angioedema due to C1-inhibitor deficiency.
Polai Z; Kajdacsi E; Cervenak L; Balla Z; Benedek S; Varga L; Farkas H
Orphanet J Rare Dis; 2023 Feb; 18(1):24. PubMed ID: 36726161
[TBL] [Abstract][Full Text] [Related]
25. Acquired Angioedema in Selected Neoplastic Diseases.
Zając M; Bożek A; Kozłowska R; Grzanka A
Medicina (Kaunas); 2023 Mar; 59(4):. PubMed ID: 37109602
[No Abstract] [Full Text] [Related]
26. Where we are with acquired angioedema due to C1 inhibitor deficiency: A systematic literature review.
Shi Y; Wang C
Clin Immunol; 2021 Sep; 230():108819. PubMed ID: 34358691
[TBL] [Abstract][Full Text] [Related]
27. Acquired C1 Inhibitor Deficiency.
Otani IM; Banerji A
Immunol Allergy Clin North Am; 2017 Aug; 37(3):497-511. PubMed ID: 28687105
[TBL] [Abstract][Full Text] [Related]
28. Acquired C1-inhibitor deficiency and lymphoproliferative disorders: a tight relationship.
Castelli R; Zanichelli A; Cicardi M; Cugno M
Crit Rev Oncol Hematol; 2013 Sep; 87(3):323-32. PubMed ID: 23490322
[TBL] [Abstract][Full Text] [Related]
29. Long term follow-up of complement parameters to improve the management of acquired angioedema due to C1-inhibitor deficiency.
Polai Z; Balla Z; Varga L; Benedek S; Farkas H
Heliyon; 2022 Nov; 8(11):e11292. PubMed ID: 36387475
[TBL] [Abstract][Full Text] [Related]
30. A novel prophylaxis with C1-inhibitor concentrate in hereditary angioedema during erythema marginatum.
Kőhalmi KV; Veszeli N; Cervenak L; Varga L; Farkas H
Immunol Lett; 2017 Sep; 189():90-93. PubMed ID: 28577900
[TBL] [Abstract][Full Text] [Related]
31. Hereditary angioedema and lupus: A French retrospective study and literature review.
Gallais Sérézal I; Bouillet L; Dhôte R; Gayet S; Jeandel PY; Blanchard-Delaunay C; Martin L; Mekinian A; Fain O
Autoimmun Rev; 2015 Jun; 14(6):564-8. PubMed ID: 25660269
[TBL] [Abstract][Full Text] [Related]
32. C-1-inhibitor binding monoclonal immunoglobins in three patients with acquired angioneurotic edema.
Chevailler A; Arlaud G; Ponard D; Pernollet M; Carrère F; Renier G; Drouet M; Hurez D; Gardais J
J Allergy Clin Immunol; 1996 Apr; 97(4):998-1008. PubMed ID: 8655897
[TBL] [Abstract][Full Text] [Related]
33. Angioedema due to acquired C1-inhibitor deficiency: a bridging condition between autoimmunity and lymphoproliferation.
Cugno M; Castelli R; Cicardi M
Autoimmun Rev; 2008 Dec; 8(2):156-9. PubMed ID: 19014872
[TBL] [Abstract][Full Text] [Related]
34. A nationwide study of acquired C1-inhibitor deficiency in France: Characteristics and treatment responses in 92 patients.
Gobert D; Paule R; Ponard D; Levy P; Frémeaux-Bacchi V; Bouillet L; Boccon-Gibod I; Drouet C; Gayet S; Launay D; Martin L; Mekinian A; Leblond V; Fain O
Medicine (Baltimore); 2016 Aug; 95(33):e4363. PubMed ID: 27537564
[TBL] [Abstract][Full Text] [Related]
35. Successful Use of Recombinant Human C1-INH in a Patient with Acquired Angioedema due to C1 Inhibitor Deficiency and an Unusually High Titer of Anti-C1-Inhibitor Autoantibodies.
Jesenak M; Brndiarova M; Banovcin P; Varga L; Farkas H
J Investig Allergol Clin Immunol; 2021 Jun; 31(3):255-256. PubMed ID: 32732186
[No Abstract] [Full Text] [Related]
36. Facial angioedema and systemic lupus erythematosus: case report.
Bienstock D; Mandel L
J Oral Maxillofac Surg; 2015 May; 73(5):928-32. PubMed ID: 25795187
[TBL] [Abstract][Full Text] [Related]
37. Autoimmune C1 inhibitor deficiency and angioedema.
Valsecchi R; Reseghetti A; Pansera B; Di Landro A
Dermatology; 1997; 195(2):169-72. PubMed ID: 9310729
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting.
Craig TJ; Bernstein JA; Farkas H; Bouillet L; Boccon-Gibod I
Int Arch Allergy Immunol; 2014; 165(2):119-27. PubMed ID: 25401373
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies.
Aygören-Pürsün E; Magerl M; Maetzel A; Maurer M
Orphanet J Rare Dis; 2018 May; 13(1):73. PubMed ID: 29728119
[TBL] [Abstract][Full Text] [Related]
40. Clinical Characteristics and Safety of Plasma-Derived C1-Inhibitor Therapy in Children and Adolescents with Hereditary Angioedema-A Long-Term Survey.
Farkas H; Kőhalmi KV; Visy B; Veszeli N; Varga L
J Allergy Clin Immunol Pract; 2020; 8(7):2379-2383. PubMed ID: 32198128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
